FDA approves drug for epilepsy-related seizures_ Briviact

“This announcement is more great medical news for epileptic patients. I have a dear friend who had uncontrolled seizures before there were effective medications. He had extensive brain resection surgery to stop the seizures to save his life. Our hearts go out to those afflicted. They need this news about Briviact.” Bill Chesnut, MD

FDA approves drug for epilepsy-related seizures_ Briviact

Reuters (2/19, Shaji) reported that the Food and Drug Administration has approved UCB SA’s epilepsy-related seizure drug, Briviact (brivaracetam). The drug was approved for patients 16 years and older as an add-on therapy for the treatment of partial seizures due to epilepsy.